Imaging3 Anticipates FDA Clearance For 3D Imaging System By Year End
This article was originally published in The Gray Sheet
Imaging3 hopes to gain long-awaited FDA clearance for its Dominion Vi three-dimensional, real-time imaging system by November, but first needs to submit an amendment to its pending 510(k) application, according to the company
You may also be interested in...
Ecolab buys O.R. Solutions
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.